JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.98B |
| 2 |
NVIDIA
NVDA
|
+$4.54B |
| 3 |
Palantir
PLTR
|
+$3.01B |
| 4 |
GE Vernova
GEV
|
+$2.54B |
| 5 |
Danaher
DHR
|
+$2.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.97B |
| 2 |
Visa
V
|
+$2.5B |
| 3 |
Amazon
AMZN
|
+$2.29B |
| 4 |
ExxonMobil
XOM
|
+$2.19B |
| 5 |
Intuitive Surgical
ISRG
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.64% |
| 2 | Financials | 9.6% |
| 3 | Consumer Discretionary | 9.3% |
| 4 | Communication Services | 7.71% |
| 5 | Healthcare | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
2901
DELISTED
Catalyst Pharmaceutical
CPRX
| $7.46M | ﹤0.01% |
378,807
-54,915
| -13% | -$1.13M |
|
2902
Knife River
KNF
$3.78B
| $7.46M | ﹤0.01% |
97,036
-10,690
| -10% | -$873K |
|
2903
Canadian Solar
CSIQ
$1.02B
| $7.46M | ﹤0.01% |
571,893
+385,355
| +207% | +$4.61M |
|
2904
PUT
Dow Inc
DOW
$22.5B
| $7.45M | ﹤0.01% |
325,000
+200,000
| +160% | +$4.98M |
|
2905
Rogers Corp
ROG
$2.54B
| $7.45M | ﹤0.01% |
92,559
+52,670
| +132% | +$3.92M |
|
2906
Cracker Barrel
CBRL
$1.28B
| $7.44M | ﹤0.01% |
168,834
+10,590
| +7% | +$612K |
|
2907
Trustmark
TRMK
$2.8B
| $7.43M | ﹤0.01% |
187,584
+18,400
| +11% | +$717K |
|
|
NSA
2908
DELISTED
National Storage Affiliates Trust
NSA
| $7.43M | ﹤0.01% |
245,781
-12,605
| -5% | -$393K |
|
2909
Collegium Pharmaceutical
COLL
$909M
| $7.41M | ﹤0.01% |
211,757
+139,689
| +194% | +$4.86M |
|
2910
PUT
Constellation Brands
STZ
$23.6B
| $7.41M | ﹤0.01% |
55,000
| – | – |
|
|
APO.PRA
2911
DELISTED
Apollo Global Management Series A
APO.PRA
| $7.4M | ﹤0.01% |
105,233
+79,175
| +304% | +$5.9M |
|
2912
Business First Bancshares
BFST
$1.04B
| $7.38M | ﹤0.01% |
312,746
-6,090
| -2% | -$151K |
|
2913
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
| $7.38M | ﹤0.01% |
145,125
-99,173
| -41% | -$5.02M |
|
2914
CALL
Analog Devices
ADI
$187B
| $7.37M | ﹤0.01% |
30,000
-8,200
| -21% | -$1.97M |
|
|
2915
PUT
Analog Devices
ADI
$187B
| $7.37M | ﹤0.01% |
30,000
+2,800
| +10% | +$673K |
|
2916
BlackRock ETF Trust II iShares AAA CLO Active ETF
CLOA
$2.26B
| $7.37M | ﹤0.01% |
141,784
+5,437
| +4% | +$282K |
|
2917
Xeris Biopharma Holdings
XERS
$1.56B
| $7.37M | ﹤0.01% |
905,076
-127,186
| -12% | -$845K |
|
2918
CALL
Tapestry
TPR
$26B
| $7.36M | ﹤0.01% |
65,000
+45,000
| +225% | +$4.71M |
|
2919
Applied Finance Valuation Large Cap ETF
VSLU
$567M
| $7.35M | ﹤0.01% |
172,237
+12,342
| +8% | +$506K |
|
2920
Agios Pharmaceuticals
AGIO
$1.98B
| $7.35M | ﹤0.01% |
183,100
-844,317
| -82% | -$31.8M |
|
2921
Mirum Pharmaceuticals
MIRM
$6.13B
| $7.35M | ﹤0.01% |
100,209
-380,067
| -79% | -$24.2M |
|
2922
Victory Capital Holdings
VCTR
$7.28B
| $7.34M | ﹤0.01% |
113,392
+668
| +0.6% | +$45.9K |
|
2923
Invesco Senior Loan ETF
BKLN
$6.76B
| $7.33M | ﹤0.01% |
350,153
-3,593,841
| -91% | -$75.3M |
|
2924
PUT
Seagate
STX
$222B
| $7.32M | ﹤0.01% |
31,000
+30,700
| +10,233% | +$5.24M |
|
|
SNDK
2925
CALL
Sandisk
SNDK
$239B
| $7.29M | ﹤0.01% |
65,000
+51,000
| +364% | +$2.98M |
|
Similar funds
JP Morgan Chase's Q3 2025 Portfolio in Review
As of Q3 2025, JP Morgan Chase held 7,834 positions worth $1.67T, up 9.1% from $1.53T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase's Q3 2025 filing shows 820 new, 3,056 increased, 2,648 reduced and 481 closed positions. Its largest new stake was Virtus Reaves Utilities ETF: 2,702,319 shares worth $225M. The largest sale was iShares Core S&P 500 ETF, an estimated $3.97B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q3 2025 buy was Virtus Reaves Utilities ETF: 2,702,319 shares worth $225M.
- JP Morgan Chase added most to Apple in Q3 2025, an estimated $4.98B increase.
- JP Morgan Chase's biggest Q3 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $3.97B.
- JP Morgan Chase fully exited The AZEK Co in Q3 2025, selling an estimated $387M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.67T portfolio in Q3 2025.
- JP Morgan Chase opened 820 new positions and closed 481 in Q3 2025.
- JP Morgan Chase's portfolio value rose 9.1% quarter-over-quarter to $1.67T.
Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.